ArticleFrontiers in oncology2023

Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Yu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.